On the other hand, SMAD2 and SMAD4 are present on 18q21.1, the prevalent region lost during CRC progression, and correlate with adenoma development and adenocarcinoma progression in mice models, thus suggesting a plausible tumor suppressor role for SMAD genes [19,96]. The gene discussed is SMAD2; the disease is colorectal carcinoma.